Companies › Immune Pharmaceuticals

Immune Pharmaceuticals

Healthcare 📍 New York, United States 👥 11-50 employees 💰 $33.2M raised 📅 Founded 2010

Immune Pharmaceuticals Inc. (NASDAQ OMX First North Premier: IMNP; OTCQX: IMNP,) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The company’s lead product candidate, Bertilimumab, is entering P

📊 Company Overview

Sector
Healthcare
Country
United States
Employees
11-50
Total Raised · Post-IPO
$33.2M
Founded
2010
Cloud
Unknown
CDN
Cloudflare

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Behind Cloudflare — actual host undetectable

Workspace🔒 Subscribers only
CDNCloudflare

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRMGoogle Analytics
CMS / Platform🔒 Subscribers only
Frontend Stack🔒 Subscribers only

Detected from Immune Pharmaceuticals's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 · Methodology · Suggest a correction